Still, one of the problems with many of the current medications is that, even with treatment, the recurrence of major depression is very high - around 70-80%. This suggests that physiological processes underlying depression - the ones that may also lead to structural changes in the brain - are not being completely arrested, and thus that a new generation of anti-depressant medications is urgently needed.